BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37301126)

  • 1. Comparison of sequential versus simultaneous integrated boost of volumetric modulated arc therapy in treatment of oropharyngeal carcinoma.
    Kachhwaha A; Tiwari R; Gayen S; Manna S; Solanki A; Devnani B; Pareek P
    Cancer Treat Res Commun; 2023; 36():100721. PubMed ID: 37301126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
    Songthong AP; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
    Radiat Oncol; 2015 Aug; 10():166. PubMed ID: 26253488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma.
    DE Felice F; Musio D; Serpone M; Vavalle G; Marchetti C; Tombolini V
    Anticancer Res; 2022 Dec; 42(12):5909-5915. PubMed ID: 36456162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experience with simultaneous integrated boost-volumetric-modulated arc therapy in the definitive treatment of head and neck cancer: An Indian data.
    Shivananjappa R; Mandal SK; Vishwanathan B; Geeta SN
    J Cancer Res Ther; 2023; 19(2):283-288. PubMed ID: 37006066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?
    Buciuman N; Marcu LG
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5311-5321. PubMed ID: 35598230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma.
    Cui T; Ward MC; Joshi NP; Woody NM; Murray EJ; Potter J; Dorfmeyer AA; Greskovich JF; Koyfman SA; Xia P
    Head Neck; 2019 Apr; 41(4):1096-1103. PubMed ID: 30702180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
    Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
    Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.
    Macchia G; Cilla S; Morganti AG; Deodato F; Legge F; Piermattei A; Chiantera V; Scambia G; Valentini V; Ferrandina G
    Acta Oncol; 2014 Feb; 53(2):251-8. PubMed ID: 24050516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: Intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy.
    Vergalasova I; Light K; Chino J; Craciunescu O
    Med Dosim; 2017 Autumn; 42(3):230-237. PubMed ID: 28711481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
    Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
    Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer.
    Mandal A; Choudhary S; Mani N; Aggarwal SK
    J Cancer Res Ther; 2020; 16(3):508-512. PubMed ID: 32719258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized comparison of simultaneous integrated boost with sequential boost intensity-modulated radiotherapy in locally advanced head and neck cancer.
    Mani N; Aggarwal SK; Kumar I; Mandal A; Jaiswal G; Ranjan R; Jaiswal AK; Gupta N; Singh A; Mourya A; Aggarwal LM; Choudhary S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S455-S459. PubMed ID: 36511003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost.
    Kim M; Lee NK; Lee S; Hwang J
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
    Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
    Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer.
    Karaca S; Aysenur Arli Karacam K
    J BUON; 2021; 26(4):1231-1238. PubMed ID: 34564975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity.
    Murakami Y; Murakami Y; Kamima T; Oguchi M; Abo N; Takahashi T; Kaneko M; Nakano M; Matsubayashi F; Harada A; Taguchi S; Hashimoto T; Yoshioka Y
    Phys Med; 2022 Mar; 95():126-132. PubMed ID: 35158316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy.
    Clemente S; Wu B; Sanguineti G; Fusco V; Ricchetti F; Wong J; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1248-55. PubMed ID: 20947268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.